UpToDate خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده:
4
September 2025
| Regimen for treatment of rifampin-resistant, fluoroquinolone-resistant TB: BPaL regimen* | |
| Bedaquiline | 400 mg once daily for two weeks, then 200 mg three times weekly for subsequent 24 weeks |
| Pretomanid | 200 mg once daily for 26 weeks |
| Linezolid | 600 mg once daily for 26 weeks |
| Regimen for treatment of rifampin-resistant, fluoroquinolone-susceptible TB: BPaLM regimen¶ | |
| Bedaquiline | 400 mg once daily for two weeks, then 200 mg three times weekly for subsequent 24 weeks |
| Pretomanid | 200 mg once daily for 26 weeks |
| Linezolid | 600 mg once daily for 26 weeks |
| Moxifloxacin | 400 mg once daily for 26 weeks |
BPaL: bedaquiline, pretomanid, and linezolid; BPaLM: bedaquiline, pretomanid, linezolid, and moxifloxacin.
* Medications should be administered seven days per week orally with food, with directly observed therapy for five of seven days per week.
¶ Medications should be administered seven days per week orally with food (avoiding milk, antacids, or other cationic items), with directly observed therapy for five of seven days per week.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
